Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

UCSD Researchers Discover Cause of Rosacea

 

August 06, 2007  |  

Doctors can describe the symptoms of rosacea, a common inflammatory skin disease that causes facial redness and affects nearly 14 million Americans.  They can tell patients what triggers can worsen their condition: spicy foods, heat, alcohol, even embarrassment.  But until now, they could not explain what caused rosacea.

A team of researchers, led by Richard L. Gallo, M.D., Ph.D., professor of medicine and chief of the Division of Dermatology at the University of California, San Diego (UCSD) School of Medicine and the Dermatology section of the Veterans Affairs San Diego Healthcare System, has determined that it is not one, but a combination of two abnormal factors, that result in rosacea.  

“It’s like having lots of gasoline…and a match,” said Gallo, principal investigator of the study which will be published in the August 5 online edition of Nature Medicine.  In essence, the researchers found that over-production of two interactive inflammatory proteins results in excessive levels of a third protein that causes rosacea symptoms, “a trifecta of unfortunate factors in people with rosacea,” according to Gallo.

Rosacea, which has been called adult acne, usually affects people with fair skin, between the ages of 30 and 60.  Unlike acne, rosacea isn’t associated with a skin infection by one type of bacteria, although antibiotics are sometimes prescribed to treat its symptoms.  A chronic condition, it gets worse over time and is generally cyclic, flaring up for a period of weeks to months, and then subsiding for a time. Current treatments are often not effective.

Gallo and his colleagues first observed in the laboratory that anti-microbial peptides – small proteins of the body’s host defense system – caused the exact same symptoms in the skin that rosacea does, such as redness, an increase in visible blood vessels, bumps or pimples.  The peptides also reacted to the same triggers.

“When we then looked at patients with the disease, every one of them had far more peptides than normal.” said Gallo. 

To learn why these patients have abnormal peptides, the researchers examined the source of these molecules. The precursor form of these peptides, called cathelicidin, is normally known for its function to protect the skin against infection.  In other skin diseases, a deficiency of cathelicidin correlates with increased infection. In rosacea patients, researchers found the opposite was true; too much cathelicidin was present in their skin.  They also observed that it was a different form than found in people without the skin disorder.

Patients with rosacea also had greatly elevated levels of enzymes called stratum corneum tryptic enzymes (SCTE). These enzymes turned the precursor into the disease-causing peptide. By injecting mice with the cathelicidin peptides found in rosacea, or adding SCTE, they increased inflammation in the mouse skin, thus proving that these abnormalities can cause the disease.

 “Too much SCTE and too much cathelicidin leads to the abnormal peptides that cause the symptoms of this disease,” said Gallo.  “Antibiotics tend to alleviate the symptoms of rosacea in patients because some of them work to inhibit these enzymes. Our findings may modify the therapeutic approach to treating rosacea, since bacteria aren’t the right target.”

Additional contributors to the research include Kenshi Yamasaki, Anna Di Nardo, Antonella Bardan, Alvin Coda, Robert A. Dorschner and Vera B. Morhenn, Division of Dermatology, UC-San Diego and VA San Diego Health Care System; Masamoto Murakami and Takaaki Ohtake, Asahikawa Medical College, Asahikawa, Japan; Chrystelle Bonnart and Pascal Descargues, Inserm and Université Paul-Sabatier, Toulouse, France; and Alan Hovnanian, CHU Purpan and Université Paul-Sabatier, Toulouse, France.

# # #

Media Contact:  Debra Kain, 619-543-6163, ddkain@ucsd.edu




Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...


Share This Article



Follow Us: